67 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell)

Page of 2 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AKR1C2Aldo-keto reductase family 1, member C2Disease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
ALADAminolevulinate dehydrataseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Transporters
Expressed in all
APEX1APEX nuclease (multifunctional DNA repair enzyme) 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
BCL2B-cell CLL/lymphoma 2Cancer-related genes
Disease related genes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted membrane proteins
Expressed in all
BLVRBBiliverdin reductase B (flavin reductase (NADPH))Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
BRAFV-raf murine sarcoma viral oncogene homolog BCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Expressed in all
CA1Carbonic anhydrase IEnzymes
FDA approved drug targets
Plasma proteins
Group enriched
CA14Carbonic anhydrase XIVEnzymes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CA3Carbonic anhydrase III, muscle specificEnzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
CCND1Cyclin D1Cancer-related genes
Disease related genes
FDA approved drug targets
Mixed
CD44CD44 molecule (Indian blood group)Blood group antigen proteins
Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
CKBCreatine kinase, brainCancer-related genes
Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
COMTCatechol-O-methyltransferaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Expressed in all
CPT1ACarnitine palmitoyltransferase 1A (liver)Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted membrane proteins
Expressed in all
CPT2Carnitine palmitoyltransferase 2Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Expressed in all
DBHDopamine beta-hydroxylase (dopamine beta-monooxygenase)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
DNMT1DNA (cytosine-5-)-methyltransferase 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Transcription factors
Expressed in all
EGFREpidermal growth factor receptorCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
EPHA2EPH receptor A2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
ESR1Estrogen receptor 1Cancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Transcription factors
Tissue enhanced
F2Coagulation factor II (thrombin)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
FASNFatty acid synthaseCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
FGF2Fibroblast growth factor 2 (basic)Cancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
RAS pathway related proteins
Mixed
FTLFerritin, light polypeptideCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Expressed in all
GANABGlucosidase, alpha; neutral ABEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
GARTPhosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetaseEnzymes
FDA approved drug targets
Plasma proteins
Expressed in all
GSRGlutathione reductaseCancer-related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Expressed in all
GSSGlutathione synthetaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HDAC1Histone deacetylase 1Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HDAC2Histone deacetylase 2Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HPRT1Hypoxanthine phosphoribosyltransferase 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
ICAM1Intercellular adhesion molecule 1Cancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
JUNJun proto-oncogeneCancer-related genes
FDA approved drug targets
Transcription factors
Expressed in all
KITV-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homologCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
LCKLymphocyte-specific protein tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
MAP2Microtubule-associated protein 2FDA approved drug targets
Plasma proteins
Tissue enriched
MAP2K2Mitogen-activated protein kinase kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
MMEMembrane metallo-endopeptidaseCancer-related genes
Candidate cardiovascular disease genes
CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
NFKB1Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1Cancer-related genes
FDA approved drug targets
Plasma proteins
RAS pathway related proteins
Transcription factors
Expressed in all
NR3C1Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Transcription factors
Expressed in all
PDGFRBPlatelet-derived growth factor receptor, beta polypeptideCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
PDXKPyridoxal (pyridoxine, vitamin B6) kinaseEnzymes
FDA approved drug targets
Plasma proteins
Expressed in all
PNPPurine nucleoside phosphorylaseCytoskeleton related proteins
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
PRDX5Peroxiredoxin 5Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Expressed in all
PRKAB1Protein kinase, AMP-activated, beta 1 non-catalytic subunitFDA approved drug targets
Expressed in all
PSMB1Proteasome (prosome, macropain) subunit, beta type, 1Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
PSMB8Proteasome (prosome, macropain) subunit, beta type, 8Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
PSMD1Proteasome (prosome, macropain) 26S subunit, non-ATPase, 1FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
PSMD2Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Expressed in all

Page of 2 | next »